Article Details
Retrieved on: 2024-08-23 22:00:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
MBX Biosciences, a Phase 2 biotech developing precision peptides for endocrine and metabolic diseases, filed on Friday with the SEC to raise up to ...
Article found on: www.renaissancecapital.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here